4//SEC Filing
Versant V Luxco S.a r.l. 4
Accession 0001140361-19-018090
CIK 0001781983other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 7:39 PM ET
Size
25.9 KB
Accession
0001140361-19-018090
Insider Transaction Report
Form 4
Transactions
- Conversion
Common Stock
2019-10-07+512,995→ 2,519,323 total - Conversion
Common Stock
2019-10-07+1,993,658→ 2,006,328 total - Conversion
Series B Convertible Preferred Stock
2019-10-07−1,993,658→ 0 total→ Common Stock (1,993,658 underlying) - Purchase
Common Stock
2019-10-07$15.00/sh+333,333$4,999,995→ 333,333 total(indirect: See footnotes) - Conversion
Series C Convertible Preferred Stock
2019-10-07−512,995→ 0 total→ Common Stock (512,995 underlying)
Transactions
- Conversion
Common Stock
2019-10-07+512,995→ 2,519,323 total - Conversion
Series B Convertible Preferred Stock
2019-10-07−1,993,658→ 0 total→ Common Stock (1,993,658 underlying) - Conversion
Series C Convertible Preferred Stock
2019-10-07−512,995→ 0 total→ Common Stock (512,995 underlying) - Conversion
Common Stock
2019-10-07+1,993,658→ 2,006,328 total - Purchase
Common Stock
2019-10-07$15.00/sh+333,333$4,999,995→ 333,333 total(indirect: See footnotes)
Versant Ventures V (Canada), L.P.
10% Owner
Transactions
- Conversion
Common Stock
2019-10-07+1,993,658→ 2,006,328 total - Conversion
Common Stock
2019-10-07+512,995→ 2,519,323 total - Purchase
Common Stock
2019-10-07$15.00/sh+333,333$4,999,995→ 333,333 total(indirect: See footnotes) - Conversion
Series C Convertible Preferred Stock
2019-10-07−512,995→ 0 total→ Common Stock (512,995 underlying) - Conversion
Series B Convertible Preferred Stock
2019-10-07−1,993,658→ 0 total→ Common Stock (1,993,658 underlying)
Versant V Luxco S.a r.l.
10% Owner
Transactions
- Conversion
Common Stock
2019-10-07+512,995→ 2,519,323 total - Purchase
Common Stock
2019-10-07$15.00/sh+333,333$4,999,995→ 333,333 total(indirect: See footnotes) - Conversion
Series B Convertible Preferred Stock
2019-10-07−1,993,658→ 0 total→ Common Stock (1,993,658 underlying) - Conversion
Common Stock
2019-10-07+1,993,658→ 2,006,328 total - Conversion
Series C Convertible Preferred Stock
2019-10-07−512,995→ 0 total→ Common Stock (512,995 underlying)
Versant Ventures V, LLC
10% Owner
Transactions
- Conversion
Common Stock
2019-10-07+1,993,658→ 2,006,328 total - Purchase
Common Stock
2019-10-07$15.00/sh+333,333$4,999,995→ 333,333 total(indirect: See footnotes) - Conversion
Series C Convertible Preferred Stock
2019-10-07−512,995→ 0 total→ Common Stock (512,995 underlying) - Conversion
Common Stock
2019-10-07+512,995→ 2,519,323 total - Conversion
Series B Convertible Preferred Stock
2019-10-07−1,993,658→ 0 total→ Common Stock (1,993,658 underlying)
Transactions
- Conversion
Series B Convertible Preferred Stock
2019-10-07−1,993,658→ 0 total→ Common Stock (1,993,658 underlying) - Conversion
Series C Convertible Preferred Stock
2019-10-07−512,995→ 0 total→ Common Stock (512,995 underlying) - Conversion
Common Stock
2019-10-07+1,993,658→ 2,006,328 total - Conversion
Common Stock
2019-10-07+512,995→ 2,519,323 total - Purchase
Common Stock
2019-10-07$15.00/sh+333,333$4,999,995→ 333,333 total(indirect: See footnotes)
Versant Affiliates Fund V, L.P.
10% Owner
Transactions
- Conversion
Series B Convertible Preferred Stock
2019-10-07−1,993,658→ 0 total→ Common Stock (1,993,658 underlying) - Conversion
Common Stock
2019-10-07+512,995→ 2,519,323 total - Purchase
Common Stock
2019-10-07$15.00/sh+333,333$4,999,995→ 333,333 total(indirect: See footnotes) - Conversion
Common Stock
2019-10-07+1,993,658→ 2,006,328 total - Conversion
Series C Convertible Preferred Stock
2019-10-07−512,995→ 0 total→ Common Stock (512,995 underlying)
Versant Venture Capital V, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2019-10-07+1,993,658→ 2,006,328 total - Conversion
Common Stock
2019-10-07+512,995→ 2,519,323 total - Purchase
Common Stock
2019-10-07$15.00/sh+333,333$4,999,995→ 333,333 total(indirect: See footnotes) - Conversion
Series B Convertible Preferred Stock
2019-10-07−1,993,658→ 0 total→ Common Stock (1,993,658 underlying) - Conversion
Series C Convertible Preferred Stock
2019-10-07−512,995→ 0 total→ Common Stock (512,995 underlying)
Footnotes (5)
- [F1]These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Common Stock ("Shares"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- [F2]These Shares and Preferred Stock are directly held by Versant V Luxco S.a r.l.
- [F3]Versant V Luxco S.a r.l. is majority owned by Versant Venture Capital V, L.P. and minority owned by Versant Ophthalmic Affiliates Fund I, L.P., Versant Affiliates Fund V, L.P. (together with Versant Venture Capital V, L.P. and Versant Ophthalmic Affiliates Fund I, L.P, the "Versant Funds") and Versant Venture Capital V (Canada) LP ("Versant Canada"). Versant Ventures V, LLC ("Ventures V") is the general partner of each of the Versant Funds. Versant Ventures V GP-GP (Canada), Inc. is the general partner of Versant Ventures V (Canada), L.P., which is the general partner of Versant Canada. Each of the Versant Funds, Versant Canada, Versant Ventures V (Canada), L.P., Versant Ventures V GP-GP (Canada), Inc. and Ventures V may be deemed to indirectly beneficially own the shares beneficially owned by Versant V Luxco S.a r.l., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein.
- [F4]These Shares are directly held by Versant Vantage I, L.P. Versant Vantage I GP-GP, LLC is the general partner of Versant Vantage I GP, L.P., which is the general partner of Versant Vantage I, L.P. Each of Versant Vantage I GP-GP, LLC and Versant Vantage I GP, L.P. may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage I, L.P., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein.
- [F5]Samuel D. Colella ("Colella"), William J. Link ("Link"), Bradley Bolzon, Ph.D ("Bolzon"), Kirk G. Nielsen ("Nielsen"), Thomas Woiwode ("Woiwode"), Jerel C. Davis ("Davis") and Robin L. Praeger ("Praeger") are managing directors of Ventures V. Bolzon, Woiwode, Davis, Praeger, and Clare Ozawa ("Ozawa") are managing directors of Versant Vantage I GP-GP, LLC. Each of Colella, Link, Bolzon, Nielsen, Woiwode, Praeger, Davis and Ozawa disclaim beneficial ownership of the Shares reported herein, except to the extent of his or her pecuniary interest therein.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
IncorporatedLuxembourg
Related Parties
1- filerCIK 0001786141
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 7:39 PM ET
- Size
- 25.9 KB